Edgar Filing: BRASKEM SA

bakpcaob1q14_6ka.htm - Generated by SEC Publisher for SEC Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K/A

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of May, 2014

(Commission File No. 1-14862 )

BRASKEM S.A.

(Exact Name as Specified in its Charter)

N/A

(Translation of registrant's name into English)

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______ No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

Braskem S.A.

Quarterly Information (ITR) at

March 31, 2014

and Independent Auditors’ Report Review

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders

Braskem S.A.

We have reviewed the accompanying condensed consolidated balance sheet of Braskem S.A. and its subsidiaries as of March 31, 2014, and the related condensed consolidated statements of operations and comprehensive income, and changes in shareholders’ equity for the three month periods ended March 31, 2014, and March 31, 2013 and the condensed consolidated statement of cash flows for the three month periods ended March 31, 2014 and March 31, 2013. These interim financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the accompanying condensed consolidated interim financial statements for them to be in conformity with IAS 34 — Interim Financial Reporting issued by the International Accounting Standard Board (IASB).

We previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet as of December 31, 2013, and the related consolidated statements of operations, comprehensive income, and changes in equity, and of cash flows for the year then ended (not presented herein), and in our report dated February 13, 2014, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of December 31, 2013, is fairly stated in all material respects in relation to the consolidated balance sheet from which it has been derived.

/s/ PricewaterhouseCoopers Auditores Independentes

Salvador-Bahia,

May 7, 2014

Braskem S.A.

Balance sheet

at March 31, 2014

All amounts in thousands of reais

Assets		Note	Mar/2014	Dec/2013
		2.1.1(a)		Revised
Current assets
	Cash and cash equivalents	3	3,214,065	4,335,859
	Financial investments	4	87,499	86,719
	Trade accounts receivable	5	2,830,606	2,810,520
	Inventories	6	5,551,054	5,033,593
	Taxes recoverable	8	2,390,438	2,237,213
	Dividends and interest on capital	7	154	150
	Prepaid expenses		46,295	62,997
	Related parties	7	456,232	124,487
	Derivatives operations	14.1.1	40,229	34,101
	Other receivables		244,598	233,808

			14,861,170	14,959,447

Non-current assets held for sale		1(a)(x)		37,681

			14,861,170	14,997,128

Non-current assets
	Financial investments	4	25,950	20,779
	Trade accounts receivable	5	18,144	61,875
	Advances to suppliers	6	104,232	116,714
	Taxes recoverable	8	1,199,760	1,285,990
	Deferred income tax and social contribution	16	806,852	1,123,313
	Judicial deposits		212,014	209,910
	Related parties	7	134,815	133,649
	Insurance claims		126,446	139,497
	Derivatives operations	14.1.1	100,995	137,345
	Other receivables		141,491	141,526
	Investments in subsidiaries and jointly-controlled investments	9	116,011	115,385
	Other investments		6,511	6,501
	Property, plant and equipment	10	25,838,557	25,413,548
	Intangible assets	11	2,883,527	2,912,630

			31,715,305	31,818,662

Total assets			46,576,475	46,815,790

The Management notes are an integral part of the financial statements

Braskem S.A.

Balance sheet

at March 31, 2014

All amounts in thousands of reais

Continued

Liabilities and shareholders' equity		Note	Mar/2014	Dec/2013
		2.1.1(a)		Revised
Current liabilities
	Trade payables		9,959,674	10,421,687
	Borrowings	12	1,224,291	1,248,804
	Project finance	13	22,676	25,745
	Derivatives operations	14.1.1	79,407	95,123
	Payroll and related charges		559,485	490,816
	Taxes payable	15	473,325	445,424
	Dividends and interest on capital		131,797	131,799
	Advances from customers		308,537	297,403
	Sundry provisions	17	88,019	105,856
	Post-employment benefits	18		158,137
	Other payables		105,172	174,007

			12,952,383	13,594,801

Non-current liabilities
	Borrowings	12	16,922,109	17,353,687
	Project finance	13	4,559,160	4,705,661
	Derivatives operations	14.1.1	382,006	396,040
	Taxes payable	15	887,743	902,875
	Long-term incentives		9,398	9,274
	Deferred income tax and social contribution	16	847,724	863,405
	Post-employment benefits	18	277,029	44,054
	Advances from customers		129,415	152,635
	Sundry provisions	17	452,980	449,694
	Other payables		777,283	662,330

			25,244,847	25,539,655

Shareholders' equity		20
	Capital		8,043,222	8,043,222
	Capital reserve		232,430	232,430
	Revenue reserves		410,149	410,149
	Other comprehensive income		(789,625)	(1,092,691)
	Treasury shares		(48,892)	(48,892)
	Accumulated profit		412,357

	Total attributable to the Company's shareholders		8,259,641	7,544,218

	Non-controlling interest in Braskem Idesa		119,604	137,116

			8,379,245	7,681,334

Total liabilities and shareholders' equity			46,576,475	46,815,790

The Management notes are an integral part of the financial statements

Braskem S.A.

Statement of operations and statement of comprehensive income

at March 31, 2014

All amounts in thousands of reais, except earnings (loss) per share

		Note	Mar/2014	Mar/2013
		2.1.1(b)		Revised

Net sales revenue		22	11,842,626	9,501,170
	Cost of products sold		(10,324,626)	(8,490,154)

Gross profit			1,518,000	1,011,016

Income (expenses)
	Selling and distribution		(269,509)	(252,039)
	General and administrative		(275,014)	(253,362)
	Research and development		(34,142)	(24,564)
	Results from equity investments	9(c)	(6)	(4,722)
	Other operating income (expenses), net	23	189,949	(28,764)

Operating profit			1,129,278	447,565

Financial results		24
	Financial expenses		(577,028)	(230,913)
	Financial income		16,883	123,112

			(560,145)	(107,801)

Profit before income tax and
social contribution			569,133	339,764

	Current and deferred income tax and social contribution	16	(172,790)	(106,866)

Profit for the period			396,343	232,898

Attributable to:
	Company's shareholders		405,306	216,007
	Non-controlling interest in Braskem Idesa		(8,963)	16,891

Profit for the period			396,343	232,898

The Management notes are an integral part of the financial statements

Braskem S.A.

Statement of operations and statement of comprehensive income

at March 31, 2014

All amounts in thousands of reais, except earnings (loss) per share

Continued

		Note	Mar/2014	Mar/2013
		2.1.1(b)		Revised

Profit for the period			396,343	232,898

Other comprehensive income or loss:
Items that will be subsequently reclassified to profit and loss:
	Fair value of cash flow hedge		24,690
	Income tax and social contribution		(8,395)
	Fair value of cash flow hedge Braskem Idesa		(20,056)
			(3,761)

	Exchange variation of foreign sales hedge	14.1.1(b.iii)	537,876
	Income tax and social contribution		(182,878)
			354,998

	Foreign currency translation adjustment		(49,669)	(3,177)

			301,568	(3,177)

Total comprehensive income for the period			697,911	229,721

Attributable to:
	Company's shareholders		715,423	209,186
	Non-controlling interest in Braskem Idesa		(17,512)	20,535

Total comprehensive income for the period			697,911	229,721

			Mar/2014	Mar/2013
		Note	Basic and Diluted	Basic and Diluted
		2.1.1(b)		Revised
Profit per share attributable to the shareholders of the Company
of continued operations at the end of the period (R$)		21
	Earnings per share - common		0.4351	0.0160
	Earnings per share - preferred shares class "A"		0.6062	0.6062
	Earnings per share - preferred shares class "B"		0.6062	0.6062

The Management notes are an integral part of the financial statements

Braskem S.A.

Statement of changes in shareholder’s equity

All amounts in thousands of reais

		Attributed to shareholders' interest
				Revenue reserves
	Note	Capital	Capital reserve	Legal reserve	Returns Earnings	Additional dividends proposed	Other comprehensive income	Treasury shares	Accumulated profit (loss)	Total Braskem shareholders' interest	Non-controlling interest in Braskem Idesa	Total shareholders' equity

At December 31, 2012		8,043,222	797,979				337,411	(48,892)	(565,549)	8,564,171	87,813	8,651,984

Comprehensive income for the period:
Profit for the period									216,007	216,007	16,891	232,898
Foreign currency translation adjustment							(6,821)			(6,821)	3,644	(3,177)
							(6,821)		216,007	209,186	20,535	229,721

Equity valuation adjustments:
Realization of additional property, plant and equipment price-level restatement, net of taxes							(6,809)		6,809
Realization of deemed cost of jointly-controlled investment, net of taxes							(242)		242
							(7,051)		7,051

Contributions and distributions to shareholders:
Loss on interest in subsidiary							(1,980)			(1,980)		(1,980)
							(1,980)			(1,980)		(1,980)

At March 31, 2013 (Revised)	2.1.1(b)	8,043,222	797,979				321,559	(48,892)	(342,491)	8,771,377	108,348	8,879,725

At December 31, 2013		8,043,222	232,430	26,895	28,412	354,842	(1,092,691)	(48,892)		7,544,218	137,116	7,681,334

Comprehensive income for the period:
Profit (loss) for the period									405,306	405,306	(8,963)	396,343
Exchange variation of foreign sales hedge, net of taxes							354,998			354,998		354,998
Fair value of cash flow hedge, net of taxes							1,253			1,253	(5,014)	(3,761)
Foreign currency translation adjustment							(46,134)			(46,134)	(3,535)	(49,669)
							310,117		405,306	715,423	(17,512)	697,911

Equity valuation adjustments:
Realization of additional property, plant and equipment price-level restatement, net of taxes							(6,810)		6,810
Realization of deemed cost of jointly-controlled investment, net of taxes							(241)		241
							(7,051)		7,051

At March 31, 2014		8,043,222	232,430	26,895	28,412	354,842	(789,625)	(48,892)	412,357	8,259,641	119,604	8,379,245

The Management notes are an integral part of the financial statements

Braskem S.A.

Statement of cash flow

at March 31, 2014

All amounts in thousands of reais

		Note	Mar/2014	Mar/2013
		2.1.1(b)		Revised

Profit before income tax and social contribution			569,133	339,764

Adjustments for reconciliation of profit
	Depreciation, amortization and depletion		505,535	485,354
	Results from equity investments	9(c)	6	4,722
	Interest and monetary and exchange variations, net		305,541	25,847
	Cost amount of the investment sold in the divestment date	23	37,662
	Provision for losses and asset write-downs of long-term		3,691	1,546

			1,421,568	857,233

Changes in operating working capital
	Held-for-trading financial investments		(4,744)	(58,272)
	Trade accounts receivable		23,282	(142,621)
	Inventories		(498,471)	(531,330)
	Taxes recoverable		(44,633)	(151,787)
	Prepaid expenses		16,702	37,157
	Other receivables (includes sale amount of subsidiary - note 23)		(332,375)	(47,919)
	Trade payables		(266,760)	(204,197)
	Taxes payable		(50,545)	(53,207)
	Long-term incentives		124	162
	Advances from customers		(12,086)	223,124
	Sundry provisions		(14,551)	(15,029)
	Other payables		184,533	256,974

Cash from operations			422,044	170,288

	Interest paid		(193,520)	(200,543)
	Income tax and social contribution paid		(22,362)	(8,440)

Net cash generated (used in) by operating activities			206,162	(38,695)

Proceeds from the sale of fixed assets			363	608
Proceeds from the sale of investments				163,000
Beginning cash of Quantiq and IQAG				9,985
Acquisitions of investments in subsidiaries and associates				(31)
Acquisitions to property, plant and equipment			(1,156,787)	(1,101,111)
Acquisitions of intangible assets			(8,870)	(524)
Held-for-maturity and available for sale financial investments			7,265	15,086

Net cash used in investing activities			(1,158,029)	(912,987)

Short-term and long-term debt
	Obtained borrowings		1,656,951	2,958,599
	Payment of borrowings		(1,841,649)	(2,285,518)
Dividends paid			(2)	(21)
Non-controlling interests in Braskem Idesa				(2,660)

Net cash provided (used in) by financing activities			(184,700)	670,400

Exchange variation on cash of foreign subsidiaries			14,773	6,383

Decrease in cash and cash equivalents			(1,121,794)	(274,899)

Represented by
	Cash and cash equivalents at the beginning for the period		4,335,859	3,287,622
	Cash and cash equivalents at the end for the period		3,214,065	3,012,723

Decrease in cash and cash equivalents			(1,121,794)	(274,899)

The Management notes are an integral part of the financial statements

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

1. Operations

Braskem S.A. is a public corporation headquartered in Camaçari, Bahia (“BA”), which jointly with its subsidiaries (hereinafter “Braskem” or “Company”), operates 36 industrial units, 29 in Brazil, 5 in the United States and 2 in Germany.

The Company is controlled by Odebrecht S.A. (“Odebrecht”), which directly and indirectly holds interests of 50.11% and 38.32% in its voting and total capital, respectively.

(a) Significant corporate and operating events impacting these financial statements

(i) The Extraordinary Shareholders Meeting (“ESM”) held on May 15, 2013 approved the increase in the capital stock of the subsidiary Braskem Idesa S.A.P.I (“Braskem Idesa”), without the issue of new shares, in the amount of R$141,620 (MXN$850,061 thousand), through capital injection of R$106,214 (MXN$637,546 thousand) by the Braskem and R$35,406 (MXN$212,515 thousand) by the non-controlling shareholder.

(ii) On July 1, 2013, Braskem acquired 2 thousand common shares of Odebrecht Comercializadora de Energia S.A. (“OCE”), equivalent to 20% of the capital of that company, whose main corporate purpose is to buy and sell electricity in the spot market. Due to the provisions in the shareholders' agreement, OCE was classified as a joint subsidiary.

(iii) On August 30, 2013, the ESM approved the merger of Rio Polímeros S.A. (“Riopol”) with Braskem Qpar S.A. (“Braskem Qpar”) and the increase in its capital from R$4,252,353 to R$7,131,165, through the issue of 293,604,915 common shares.

(iv) On September 19, 2013, the Braskem S.A. and Braskem Austria acquired the shares issued by Braskem Mexico and held by Braskem Participações and Braskem Importação e Exportação Ltda. (“Braskem Importação”) for R$1,803 and R$1, respectively.

(v) On November 1, 2013, approval was given to increase the capital of the subsidiary Distribuidora de Águas Triunfo S.A. (“DAT”) through the transfer of assets of the Water Treatment Unit (“WTU”) at the Basic Petrochemicals Unit in the Triunfo Petrochemical Complex in Rio Grande do Sul, amounting to R$37,561. On December 27, 2013, approval was given to another capital increase of DAT of R$151 through a new transfer of assets, after which the capital increased to R$37,717.

(vi) On November 21, 2013, Braskem Mexico constituted Braskem Mexico Servicios S. de R. L. de C.V. (“Braskem Mexico Serviços”), whose capital amounts to MXN$3 thousand. The purpose of this subsidiary is to provide services to Braskem Idesa.

(vii) On November 27, 2013, Common Industries Ltd. (“Common”) repurchased and canceled 49,995 of its shares held by Braskem Qpar for US$2,591 thousand. On the same date, Braskem Incorporated Limited (“Braskem Inc”) acquired 5 common shares of Common, also held by Braskem Qpar, for US$259 and Braskem Inc. became the sole shareholder.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(viii) On December 17, 2013, the Braskem S.A. entered into a share sales agreement (“Agreement”) with Solvay Argentina S.A. (“Solvay Argentina”), through which it committed to acquire, upon the fulfillment of certain conditions provided for in the Agreement ("Acquisition"), shares representing 70.59% of the total and voting capital of Solvay Indupa S.A.I.C. (“Solvay Indupa”).

Solvay Indupa, which produces PVC and caustic soda, has two integrated production sites located in: (i) Santo André, (SP), with the capacity to produce 300 kton of PVC* and 170 kton of caustic soda*; and (ii) Bahía Blanca in the Province of Buenos Aires, Argentina, with the capacity to produce 240 kton of PVC* and 180 kton of caustic soda*.

The Agreement provides for the acquisition by Braskem of 292,453,490 shares representing 70.59% of the total and voting capital of Solvay Indupa that are held by Solvay Argentina, at the price of US$ 0.085, to be paid upon the settlement of the acquisition. The acquisition price is based on the Enterprise Value of US$290 million.

Meanwhile, Solvay Indupa holds, as of December 31, 2013, (i) 158,534,671 shares in Solvay Indupa do Brasil S.A. (“Indupa Brasil”) representing 99.99% of the total and voting capital of Indupa Brasil; and (ii) 1,010,638 shares in Solalban Energía S.A. (“Solalban”) representing 58.00% of the total and voting capital of Solalban. As a result of the Acquisition, Braskem will become an indirect shareholder of Indupa Brasil and of Solalban.

As a result of the Acquisition, Braskem carried out a public tender offer on December 18, 2013 for shares representing 29.41% of the capital of Solvay Indupa traded on the Buenos Aires Stock Exchange - BCBA, pursuant to governing legislation, and also plans to cancel the registration of Solvay Indupa at the Securities and Exchange Commission of Brazil (“CVM”).

The conclusion and effective implementation of the acquisition is subject to, among other operational conditions, approval by Brazil’s antitrust agency CADE (Administrative Council for Economic Defense).

(ix) On December 30, 2013, Quantiq changed its corporate type to limited liability company, with its new name being Quantiq Distribuidora Ltda.

(x) On December 31, 2013, Braskem entered into a share sales agreement with Odebrecht Ambiental (“OA”), through which it sold its interest in the subsidiary DAT for R$315 million, to be received during the course of 2014.

The assets of DAT were shown in the balance sheet of December 31, 2013 as “assets available for sale.” DAT did not register results or hold liabilities in the year ended on December 31, 2013.

On February 3, 2014, the Extraordinary Shareholders’ Meeting of DAT approved the change in its Management and consequently the transfer of the management of the operations of DAT to OA, upon the recognition of a net gain of R$277,338.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(b) Effect of foreign exchange variation

The Company is exposed to foreign exchange variation on the balances and transactions made in currencies other than its functional currencies, particularly in U.S. dollar, such as financial investments, trade accounts receivable, trade payables, borrowings and sales. In addition to the exchange effect of the U.S. dollar in relation to the Brazilian real, Braskem is exposed to the U.S. dollar through its subsidiaries abroad, particularly in which the functional currency is Euro or Mexican peso. The balances of assets and liabilities are translated based on the exchange rate at the end of each period, while transactions are based on the effective exchange rate on the date of each operation.

The following table shows the U.S. dollar average and end-of-period exchange rates for the periods in this report:

Effect of foreign exchange variation

End of period rate

U.S. dollar - Brazilian real, Mar/2014	2.2630	U.S. dollar - Mexican peso, Mar/2014	13.0595	U.S. dollar - euro, Mar/2014	0.7259
U.S. dollar - Brazilian real, Dec/2013	2.3426	U.S. dollar - Mexican peso, Dec/2013	13.1005	U.S. dollar - euro, Dec/2013	0.7260
Devaluation of the U.S. dollar in relation to the Brazilian real	-3.40%	Devaluation of the U.S. dollar in relation to the Mexican peso	-0.31%	Devaluation of the U.S. dollar in relation to the euro	-0.02%

Average rate for the period

U.S. dollar - Brazilian real, Mar/2014	2.3652	U.S. dollar - Mexican peso, Mar/2014	13.2311	U.S. dollar - euro, Mar/2014	0.7300
U.S. dollar - Brazilian real, Mar/2013	1.9977	U.S. dollar - Mexican peso, Mar/2013	12.6419	U.S. dollar - euro, Mar/2013	0.7578
Appreciation of the U.S. dollar in relation to the Brazilian real	18.40%	Appreciation of the U.S. dollar in relation to the Mexican peso	4.66%	Devaluation of the U.S. dollar in relation to the euro	-3.67%

2. Summary of significant accounting policies

2.1. Basis of preparation

This Quarterly Information should be read together with the financial statements of Braskem as of December 31, 2013, which were prepared and presented in accordance with the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB).

The preparation of the quarterly information requires the use of certain critical accounting estimates. It also requires the Management of the Company to exercise its judgment in the process of applying its accounting policies. There were no significant changes in the assumptions and judgments made by the Company’s management in the use of estimates for the preparation of the Quarterly Information in relation to those used in the December 31, 2013 financial statements.

On March 31, 2014, the Company started to include in its balance sheet the net value, per legal entity, of the amounts related to deferred income and social contribution tax assets and liabilities on its profit as the Company has the legally enforceable right to offset these amounts. The balance sheet at December 31, 2013 was revised to reflect such adjustment, as shown in Note 2.1.1(a).

2.1.1 Revised

The financial statements for the period ended December 31, 2013 and March 31, 2013 were revised as follows:

(a) December 31, 2013 – The balance sheets and respective notes were revised to reflect deferred Income Tax (“IR”) and Social Contribution (“CSL”) on a net basis (Note 2.1); and

(b) March 31, 2013 – The statements of operations, equity, cash flows and respective notes were revised to include the results of the operations of Quantiq Distribuidora Ltda. (“Quantiq”) and IQAG Armazéns Gerais Ltda. (“IQAG”) as a result of the Company’s decision to sell these assets.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

The effects of the revision of the financial statements follow:

Balance Sheet

Dec/2013

Published

(a) Effects

Revised

Assets

Current assets

14,997,128

Non-current assets

Deferred income tax and social contribution

2,653,606

(1,530,293)

1,123,313

Other assets

30,695,349

33,348,955

(1,530,293)

31,818,662

Total assets

48,346,083

(1,530,293)

46,815,790

Liabilities and shareholders' equity

Current liabilities

13,594,801

Non-current liabilities

Deferred income tax and social contribution

2,393,698

(1,530,293)

863,405

Other liabilities

24,676,250

27,069,948

(1,530,293)

25,539,655

Shareholders' equity

7,681,334

Total liabilities and shareholders' equity

48,346,083

(1,530,293)

46,815,790

Statement of operations for the period

		Mar/2013
		Published	(b) Effects	Revised

Net sales revenue		9,295,751	205,419	9,501,170
	Cost of products sold	(8,315,675)	(174,479)	(8,490,154)

Gross profit		980,076	30,940	1,011,016

Income (expenses)
	Selling and distribution	(246,372)	(5,667)	(252,039)
	General and administrative	(237,006)	(16,356)	(253,362)
	Research and development	(24,564)	-	(24,564)
	Results from equity investments	(4,722)	-	(4,722)
	Other operating income (expenses), net	(29,055)	291	(28,764)

Operating profit		438,357	9,208	447,565

Financial results
	Financial expenses	(230,050)	(863)	(230,913)
	Financial income	122,864	248	123,112

		(107,186)	(615)	(107,801)

Profit before income tax and
social contribution		331,171	8,593	339,764

	Current and deferred income tax and social contribution	(104,368)	(2,498)	(106,866)

Profit for the period
		226,803	6,095	232,898

Attributable to:
	Company's shareholders	209,912	6,095	216,007
	Non-controlling interest in Braskem Idesa	16,891	-	16,891

		226,803	6,095	232,898

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

Statement of cash flows

		Mar/2013
		Published	(b) Effects	Revised

Profit before income tax and social contribution		331,171	8,593	339,764

Adjustments for reconciliation of profit
	Depreciation, amortization and depletion	483,446	1,908	485,354
	Results from equity investments	4,722		4,722
	Interest and monetary and exchange variations, net	25,836	11	25,847
	Provision for losses and asset write-downs of long-term	1,546		1,546
		846,721	10,512	857,233

Changes in operating working capital
	Held-for-trading financial investments	(58,272)		(58,272)
	Trade accounts receivable	(119,761)	(22,860)	(142,621)
	Inventories	(526,189)	(5,141)	(531,330)
	Taxes recoverable	(149,086)	(2,701)	(151,787)
	Prepaid expenses	37,768	(611)	37,157
	Other receivables	(78,302)	30,383	(47,919)
	Trade payables	(195,916)	(8,281)	(204,197)
	Taxes payable	(52,697)	(510)	(53,207)
	Long-term incentives	162		162
	Advances from customers	223,562	(438)	223,124
	Sundry provisions	(15,168)	139	(15,029)
	Other payables	256,646	328	256,974

Cash from operations		169,468	820	170,288

	Interest paid	(200,543)		(200,543)
	Income tax and social contribution paid	(8,440)		(8,440)

Net cash generated (used in) by operating activities		(39,515)	820	(38,695)

Proceeds from the sale of fixed assets		608		608
Proceeds from the sale of investments		163,000		163,000
Beginning cash of Quantiq and IQAG			9,985	9,985
Acquisitions of investments in subsidiaries and associates		(31)		(31)
Acquisitions to property, plant and equipment		(1,101,042)	(69)	(1,101,111)
Acquisitions of intangible assets		(524)		(524)
Held-for-maturity and available for sale financial investments		15,086		15,086

Net cash generated (used in) investing activities		(922,903)	9,916	(912,987)

Short-term and long-term debt
	Obtained borrowings	2,958,599		2,958,599
	Payment of borrowings	(2,285,304)	(214)	(2,285,518)
Dividends paid		(21)		(21)
Non-controlling interests in Braskem Idesa		(2,660)		(2,660)

Net cash provided (used in) by financing activities		670,614	(214)	670,400

Exchange variation on cash of foreign subsidiaries		6,383		6,383

Increase (decrease) in cash and cash equivalents		(285,421)	10,522	(274,899)

Represented by
	Cash and cash equivalents at the beginning for the period	3,287,622		3,287,622
	Cash and cash equivalents at the end for the period	3,002,201	10,522	3,012,723

Increase (decrease) in cash and cash equivalents		(285,421)	10,522	(274,899)

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

2.1.2 Consolidated quarterly information

The consolidated Quarterly Information was prepared and is being presented in accordance with the pronouncement IAS 34 - Interim Financial Reporting, which establish the minimum content for interim financial statements.

2.2. Accounting policies

There were no changes in the accounting practices used in the preparation of the Quarterly Information in relation to those presented in the December 31, 2013 financial statements, except as presented in Notes 2.2.1.

2.2.1 Deferred income tax and social contribution

Deferred income and social contribution tax assets and liabilities are stated at their net value in the balance sheet when there is a legal and enforceable right to offset current income and social contribution taxes, related to the same legal entity and tax authority. The effects of this change in accounting practice are described in Note 2.1.1 (a).

2.2.2 Transaction costs with debt refinancing

Costs incurred with debt refinancing that meet the qualitative and quantitative criteria determined by the standards for reclassification as a debt exchange, are deemed transaction costs and amortized through the maturity of the refinanced debt. The effects of said accounting treatment are reported in Note 12 (a).

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

2.3. Consolidated quarterly information

The consolidated quarterly information includes the quarterly information of Braskem companies in which it, directly or indirectly, maintains a controlling equity interest or controls the activities, as presented below:

		Total interest - %
		Headquarters
		(Country)	Mar/2014	Dec/2013
Direct and Indirect subsidiaries
Braskem America Finance Company ("Braskem America Finance")		USA	100.00	100.00
Braskem America, Inc. (“Braskem America”)		USA	100.00	100.00
Braskem Argentina S.A. (“Braskem Argentina”)		Argentina	100.00	100.00
Braskem Austria		Austria	100.00	100.00
Braskem Austria Finance GmbH ("Braskem Austria Finance")		Austria	100.00	100.00
Braskem Chile Ltda. ("Braskem Chile")		Chile	100.00	100.00
Braskem Europe GmbH ("Braskem Alemanha")		Germany	100.00	100.00
Braskem Finance Limited (“Braskem Finance”)		Cayman Islands	100.00	100.00
Braskem Idesa		Mexico	75.00	75.00
Braskem Idesa Servicios S.A. de CV ("Braskem Idesa Serviços")		Mexico	75.00	75.00
Braskem Importação		Brazil	100.00	100.00
Braskem Inc		Cayman Islands	100.00	100.00
Braskem México		Mexico	100.00	100.00
Braskem México Serviços		Mexico	100.00	100.00
Braskem Netherlands B.V (“Braskem Holanda”)		Netherlands	100.00	100.00
Braskem Participações		Brazil	100.00	100.00
Braskem Petroquímica Chile Ltda. (“Petroquímica Chile”)		Chile	100.00	100.00
Braskem Petroquímica Ibérica, S.L. ("Braskem Espanha")		Spain	100.00	100.00
Braskem Petroquímica Ltda ("Braskem Petroquímica")		Brazil	100.00	100.00
Braskem Qpar		Brazil	100.00	100.00
Common	(i)	British Virgin Islands	100.00	100.00
DAT		Brazil		100.00
IQAG		Brazil	100.00	100.00
Lantana Trading Co. Inc. (“Lantana”)		Bahamas	100.00	100.00
Norfolk Trading S.A. (“Norfolk”)	(i)	Uruguay	100.00	100.00
Politeno Empreendimentos Ltda. (“Politeno Empreendimentos”)		Brazil	100.00	100.00
Quantiq		Brazil	100.00	100.00

Specific Purpose Entity ("SPE")
Fundo de Investimento Multimercado Crédito Privado Sol (“FIM Sol”)		Brazil	100.00	100.00
Fundo de Investimento Caixa Júpiter Multimercado Crédito Privado
Longo Prazo ("Fundo Júpiter)		Brazil	100.00	100.00

(i) Subsidiaries in the process of dissolution.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

3. Cash and cash equivalents

The information on cash and cash equivalents were presented in the 2013 annual financial statements of the Company, in Note 7.

		Mar/2014	Dec/2013

Cash and banks (i)		240,089	987,824
Cash equivalents:
	Domestic market	1,659,926	1,906,790
	Foreign market (i)	1,314,050	1,441,245
Total		3,214,065	4,335,859

(i) Includes the amount of R$44,272 and R$105,778 corresponding to cash and bank and cash equivalents, respectively, of the subsidiary Braskem Idesa, available for its use.

4. Financial investments

The information on financial investments was presented in the 2013 annual financial statements of the Company, in Note 8.

			Mar/2014	Dec/2013
Held-for-trading
	Investments in FIM Sol		66,962	61,670
	Investments in foreign currency		2,955	3,773
	Shares		1,170	1,170
Held-to-maturity
	Quotas of investment funds in credit rights	(i)	42,003	40,696
	Time deposit investment		359	189
	Investments in foreign currency	(ii)	455,143	469,376
	Compensation of investments in foreign currency	(ii)	(455,143)	(469,376)
Total			113,449	107,498

In current assets			87,499	86,719
In non-current assets			25,950	20,779
Total			113,449	107,498

(i) On March 31, 2014, Braskem S.A. held junior subordinated shares issued by receivables-backed investment funds. These shares are measured by their redemption value and are held until the conclusion of operations of said funds. The funds issue two other types of shares that enjoy priority in compensation over the junior subordinated shares. The risk related to the operations of these funds is limited to the value of the shares held by the Braskem S.A..

(ii) On March 31, 2014, Braskem Holanda had a financial investments held-to-maturity that was irrevocably offset by an export prepayment agreement of the Braskem S.A., in the same amount, as provided for in the credit assignment agreement entered into between these two companies and Banco Bradesco (Note 12). This accounting offset was carried out in accordance with IAS 32, which provides for the possibility of offsetting financial instruments when there is intent and rightfully executable right to realize an asset and settle a liability simultaneously.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

5. Trade accounts receivable

The information on trade accounts receivable was presented in the 2013 annual financial statements of the Company, in Note 9.

		Mar/2014	Dec/2013
Consumers
	Domestic market	1,591,445	1,578,008
	Foreign market	1,549,396	1,577,140
Allowance for doubtful accounts		(292,091)	(282,753)
Total		2,848,750	2,872,395

In current assets		2,830,606	2,810,520
In non-current assets		18,144	61,875
Total		2,848,750	2,872,395

6. Inventories

The information on inventories was presented in the 2013 annual financial statements of the Company, in Note 10.

	Mar/2014	Dec/2013

Finished goods	3,575,331	3,429,979
Raw materials, production inputs and packaging	1,400,234	1,113,272
Maintenance materials	251,892	230,822
Advances to suppliers	204,195	236,672
Imports in transit and other	223,634	139,562
Total	5,655,286	5,150,307

In current assets	5,551,054	5,033,593
In non-current assets	104,232	116,714
Total	5,655,286	5,150,307

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

7. Related parties

The information concerning related parties was presented in the 2013 annual financial statements of the Company, in Note 11.

Balances at March 31, 2014

Assets

Liabilities

Current

Non-current

Current

Trade accounts receivable

Related parties

Other

Total

Related parties

Other

Total

Trade payables

Receivable notes

Other receivable

Loan agreements

Other receivable

Jointly-controlled investment

Refinaria de Petróleo Riograndense S.A. ("RPR")

151

(i)

151

2,462

OCE

(i)

154

2,462

Associated companies

Borealis Brasil S.A. ("Borealis")

19,860

187

20,047

19,860

187

20,047

Related companies

Odebrecht and subsidiaries

3,640

391,652

(iii)

52,799

(ii)

448,141

104,232

(ii)

104,232

212,088

Petrobras and subsidiaries

34,875

9,925

54,418

4,028

(ii)

103,246

68,513

66,302

134,815

1,660,365

Other

14,929

53,444

401,577

54,468

56,827

566,316

68,513

66,302

104,232

239,047

1,872,453

Total

73,304

401,764

54,468

56,981

586,517

68,513

66,302

104,232

239,047

1,874,915

(i)         Amounts in “dividends and interest on capital”
(ii)       Amount in “inventory – advance to suppliers” (Note 6)
(iii)      Includes the amount of R$315,000 related to the divestment of DAT (Note 1 (a.x))

	Income statement transactions from January to March 31, 2014
		Purchases of		Cost of
		raw materials,	Financial	production/general
	Sales	services and	income	and administrative
	of products	utilities	(expenses)	expenses

Jointly-controlled investment
RPR	3,182	5,715
	3,182	5,715

Associated companies
Borealis	51,103
	51,103

Related companies
Odebrecht and subsidiaries	8,845	49,933
Petrobras and subsidiaries	303,220	2,110,336	1,166
Other	5,267	37
	317,332	2,160,306	1,166

Post employment benefit plan
Odebrecht Previdência Privada ("Odeprev")				6,037
				6,037


Total	371,617	2,166,021	1,166	6,037

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

Balances at December 31, 2013

Assets

Liabilities

Current

Non-current

Current

Trade accounts receivable

Related parties

Other

Total

Related parties

Other

Total

Trade payables

Receivable notes

Other receivable

Loan agreements

Other receivable

Jointly-controlled investment

RPR

150

(i)

150

3,106

150

3,106

Associated companies

Borealis

11,368

187

11,555

11,368

187

11,555

Related companies

Odebrecht and subsidiaries

440

78,068

37,436

(ii)

115,944

782,565

(iii)

782,565

533,498

Petrobras and subsidiaries

99,018

9,925

36,307

42,013

(ii)

187,263

67,348

66,301

133,649

1,833,040

Other

15,135

114,593

9,925

114,375

79,449

318,342

67,348

66,301

782,565

916,214

2,366,538

Total

125,961

10,112

114,375

79,599

330,047

67,348

66,301

782,565

916,214

2,369,644

(i) Amounts in “dividends and interest on capital”.
(ii) Amount in “inventory – advance to suppliers” (Note 6)
(iii)Amount of R$665,851 under “Property, plant and equipment” related to ongoing construction works, and R$116,714 under “inventory – advance to suppliers” (Note 6).

	Income statement transactions from January to March 31, 2013
		Purchases of		Cost of
		raw materials,	Financial	production/general
	Sales	services and	income	and administrative
	of products	utilities	(expenses)	expenses

Jointly-controlled investment
RPR	7,428	11,702
	7,428	11,702

Associated companies
Borealis	50,445
Other	7,874	2,018
	58,319	2,018

Related companies
Odebrecht and subsidiaries		125,267
Petrobras and subsidiaries	299,884	4,794,408	329
	299,884	4,919,675	329

Post employment benefit plan
Odeprev				4,410
				4,410


Total	365,631	4,933,395	329	4,410

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(a) Key management personnel

The Company considered as “Key management personnel” the members of the Board of Directors and Board of Executive Officers, composed of the Chief Executive Officer and vice-presidents. Not all members of the Board of Executive Officers are members of the Statutory Board of Executive Officers.


Non-current liabilities	Mar/2014	Dec/2013

Long-term incentives	1,685	2,333
Total	1,685	2,333



Income statement transactions	Mar/2014	Mar/2013
Remuneration
Short-term benefits to employees and managers	3,486	4,728
Post-employment benefit	76	68
Long-term incentives	22	42
Total	3,584	4,838

8. Taxes recoverable

The information on taxes recoverable was presented in the 2013 annual financial statements of the Company, in Note 12.

			Mar/2014	Dec/2013
Brazil
	IPI		31,692	28,701
	Value-added tax on sales and services (ICMS) - normal operations		629,371	738,282
	ICMS - credits from PP&E		127,181	123,354
	Social integration program (PIS) and social contribution on revenue (COFINS) - normal operations		773,488	719,448
	PIS and COFINS - credits from PP&E		281,057	269,006
	PIS and COFINS - Law 9,718/98		13,274	24,207
	PIS - Decree-Law 2,445 and 2,449/88		88,339	88,339
	IR and CSL		548,799	542,686
	REINTEGRA program		238,283	267,049
	Other		150,873	155,965

Other countries
	Value-added tax	(a)	704,623	563,650
	Income tax		3,218	2,516
Total			3,590,198	3,523,203

Current assets			2,390,438	2,237,213
Non-current assets			1,199,760	1,285,990
Total			3,590,198	3,523,203

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(a) Value added tax (“VAT”)

On March 31, 2014, this line included:

(i) R$34,823 from sales by Braskem Alemanha to other countries. These credits are refunded in cash by the local government; and

(ii) R$661,337 from purchases of machinery and equipment for the Ethylene XXI Project (Note 10). These credits will be reimbursed, in cash, by the Mexican government, after their validation. The Company expects to recover these credits at the short term.

9. Investments

The information related to investments was presented in the Company’s annual financial statements, in Note 16.

(a) Information on investments


				Interest in total capital		Adjusted net profit (loss)		Adjusted
				total (%) - Mar/2014		for the period		equity
			Note	Direct	Direct and Indirect	Mar/2014	Mar/2013	Mar/2014	Dec/2013
			2.1.1(b)				Revised
Jointly-controlled investment
	RPR			33.20	33.20	324	2,455	125,303	124,980
	OCE	(i)		20.00	20.00	159		489	689
	Propilsur			49.00	49.00	(88)	(556)	111,561	109,300

Associates
	Borealis			20.00	20.00		16,102	166,746	166,746
	Companhia de Desenvolvimento Rio Verde ("Codeverde")			35.97	35.97	(197)	(596)	44,947	46,342

(i) Shares acquired in July 2013 (Note 1(a.ii)).

(b) Changes in investments


		Dividends		Currency
	Balance at	and interest	Effect	translation	Balance at
	Dec/2013	on equity	of results	adjustments	Mar/2014
Jointly-controlled investments
Propilsur	40,398		(74)	633	40,957
RPR	41,500		107		41,607
OCE	138	(3)	(37)		98
	82,036	(3)	(4)	633	82,662

Associate
Borealis	33,349				33,349
Total associate	33,349				33,349


Total jointly-controlled investments and associate	115,385	(3)	(4)	633	116,011

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(c) Breakdown of equity accounting results

	Mar/2014	Mar/2013
Equity in results of subsidiaries, associate and jointly-controlled investment	(6)	(4,722)
	(6)	(4,722)

10. Property, plant and equipment

The information on property, plant and equipment was presented in the Company’s 2013 annual financial statements, in Note 17.


			Mar/2014			Dec/2013
		Accumulated			Accumulated
		depreciation/			depreciation/
	Cost	depletion	Net	Cost	depletion	Net

Land	425,228		425,228	428,908		428,908
Buildings and improvements	1,840,548	(798,978)	1,041,570	1,830,245	(783,084)	1,047,161
Machinery, equipment and installations	25,852,670	(11,444,109)	14,408,561	25,671,115	(11,044,102)	14,627,013
Projects in progress	9,476,536		9,476,536	8,832,906		8,832,906
Other	963,315	(476,653)	486,662	936,228	(458,668)	477,560
Total	38,558,297	(12,719,740)	25,838,557	37,699,402	(12,285,854)	25,413,548

Impairment test for property, plant and equipment

There were no significant events or circumstances in the period ended March 31, 2014 that indicate the need for impairment testing on the property, plant and equipment.

11. Intangible assets

The information on intangible assets was presented in the 2013 annual financial statements of the Company, in Note 18.

			Mar/2014	Dec/2013
		Accumulated			Accumulated
	Cost	amortization	Net	Cost	amortization	Net

Goodwill based on future profitability	3,187,722	(1,128,804)	2,058,918	3,187,722	(1,128,804)	2,058,918
Trademarks and patents	211,283	(84,185)	127,098	208,574	(82,176)	126,398
Software and use rights	479,430	(257,988)	221,442	473,560	(244,924)	228,636
Contracts with customers and suppliers	700,442	(224,373)	476,069	712,499	(213,821)	498,678
Total	4,578,877	(1,695,350)	2,883,527	4,582,355	(1,669,725)	2,912,630

Impairment of intangible assets with definite and indefinite useful life

There were no significant events or circumstances in the period ended March 31, 2014 that indicated the need for updating the impairment testing of intangible assets with indefinite useful life made in October 2013, or that indicated the need to perform an impairment testing of intangible assets with definite useful life.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

12. Borrowings

The information on borrowings was presented in the 2013 annual financial statements of the Company, in Note 19.

		Annual financial charges
			Average interest (unless otherwise stated)
		Monetary restatement	Average interest (unless otherwise stated)	Mar/2014	Dec/2013
Foreign currency
	Bonds and Medium term notes (MTN)	Note 12 (a)	Note 12 (a)	10,061,916	10,432,526
	Advances on exchange contracts	US dollar exchange variation	1.24%	113,386	117,132
	Export prepayment	Note 12 (b)	Note 12 (b)	524,995	540,744
	BNDES	Note 12 (c)	Note 12 (c)	412,522	453,065
	Export credit notes	Note 12 (d)	Note 12 (d)	816,937	843,060
	Working capital	US dollar exchange variation	1.77% above Libor	781,785	633,632
	Other	US dollar exchange variation	4.00% above Libor	1,241	1,268
	Transactions costs			(229,049)	(81,375)

Local currency
	Export credit notes	Note 12 (d)	Note 12 (d)	2,623,356	2,528,077
	BNDES	Note 12 (c)	Note 12 (c)	2,407,563	2,464,987
	BNB/ FINAME/ FINEP/ FUNDES		6.48%	634,305	658,372
	BNB/ FINAME/ FINEP/ FUNDES	TJLP	0.38%	14,191	16,093
	Transactions costs			(16,748)	(5,090)
Total				18,146,400	18,602,491

Current liabilities				1,224,291	1,248,804
Non-current liabilities				16,922,109	17,353,687
Total				18,146,400	18,602,491

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(a) Bonds and MTN

		Issue amount		Interest
Issue date		(US$ in thousands)	Maturity	(% per year)	Mar/2014	Dec/2013
July 1997		250,000	June 2015	9.38	150,574	152,328
January 2004		250,000	January 2014	11.75		178,897
September 2006	(i)	275,000	January 2017	8.00	185,369	305,006
June 2008	(i)	500,000	June 2018	7.25	423,915	1,000,375
May 2010	(i)	400,000	May 2020	7.00	539,290	940,780
May 2010		350,000	May 2020	7.00	814,073	828,360
October 2010		450,000	no maturity date	7.38	1,036,291	1,072,742
April 2011		750,000	April 2021	5.75	1,736,173	1,772,070
July 2011		500,000	July 2041	7.13	1,146,728	1,207,927
February 2012		250,000	April 2021	5.75	580,660	592,666
February 2012		250,000	no maturity date	7.38	575,718	595,968
May 2012		500,000	May 2022	5.38	1,156,503	1,181,443
July 2012		250,000	July 2041	7.13	573,364	603,964
February 2014	(i)	500,000	February 2024	6.45	1,143,258
Total		5,475,000			10,061,916	10,432,526

(i) The Bonds issued in February 2014 had the primary objective of refinancing the Bonds issued in September 2006, June 2008 and May 2010. The operation was considered a refinancing of said debt, in accordance with IFRS 9, for which reason all expenses involved in structuring the February 2014 operation and Bond exchange were considered transaction costs.

(b) Export prepayments (“EPP”)

	Initial amount
	of the transaction
Issue date	(US$ thousand)	Maturity	Charges (% per year)	Mar/2014	Dec/2013
December 2010	100.000	December-2017	US dollar exchange variation + semiannual Libor + 2.47	115,576	118,505
January 2013	200.000	November-2022	US dollar exchange variation + semiannual Libor + 2.47	409,419	422,239
Total	300.000			524,995	540,744

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(c) BNDES borrowings

Projects	Issue date	Maturity	Charges (% per year)	Mar/2014	Dec/2013

Foreign currency
Other	2006	October-2016	US dollar exchange variation + 6.79	5,754	6,533
Braskem Qpar expansion	2006/2007/2008	April-2016	US dollar exchange variation + 6.64 to 6.79	8,957	10,389
Green PE plant	2009	July-2017	US dollar exchange variation + 6.57	35,797	39,838
Limit of credit II	2009	January-2017	US dollar exchange variation + 6.57	71,746	80,826
New plant PVC Alagoas	2010	January-2020	US dollar exchange variation + 6.57	106,598	115,082
Limit of credit III	2011	October-2018	US dollar exchange variation + 6.41 to 6.44	145,948	159,917
Butadiene plant	2011	January-2021	US dollar exchange variation + 6.44	37,722	40,480
				412,522	453,065

Local currency
Other	2006	September-2016	TJLP + 2.80	44,804	49,294
Braskem Qpar expansion	2006/2007/2008	February-2016	TJLP + 2.15 to 3.30	67,037	75,867
Green PE plant	2008/2009	June-2017	TJLP + 0.00 to 4.78	260,054	280,631
Limit of credit II	2009	January-2017	TJLP + 2.58 to 3.58	221,334	240,915
Limit of credit II	2009	January-2017	4.50	9,889	10,763
New plant PVC Alagoas	2010	December-2019	TJLP + 0.00 to 3.58	337,578	352,364
New plant PVC Alagoas	2010	December-2019	5.50	38,415	40,091
Limit of credit III	2011	October-2019	TJLP + 0.00 to 3.58	980,041	969,715
Limit of credit III	2011	October-2019	SELIC + 2.58	93,530	82,362
Limit of credit III	2011	November-2019	3.50 to 5.50	225,306	228,583
Butadiene plant	2011	December-2020	TJLP + 0.00 to 3.45	129,575	134,402
				2,407,563	2,464,987

Total				2,820,085	2,918,052

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(d) Export credit notes (“NCE”)

		Initial amount
Issue date		of the transaction	Maturity	Charges (% per year)	Mar/2014	Dec/2013

Foreign currency
November 2006		167,014	May 2018	Us dollar exchange variation + 8.10	182,074	184,778
April 2007		101,605	March 2018	Us dollar exchange variation + 7.87	117,429	119,255
May 2007		146,010	May 2019	Us dollar exchange variation + 7.85	174,129	176,806
January 2008		266,430	February 2020	Us dollar exchange variation + 7.30	343,305	362,221
		681,059			816,937	843,060

Local currency
April-2010		50,000	October-2021	105% of CDI	52,164	50,880
June-2010		200,000	October-2021	105% of CDI	208,656	203,521
February-2011		250,000	October-2021	105% of CDI	208,656	203,521
April-2011	(i)	450,000	April-2019	112.5% of CDI	459,852	459,408
June-2011		80,000	October-2021	105% of CDI	83,462	81,408
August-2011	(i)	400,000	August-2019	112.5% of CDI	403,603	403,513
June-2012		100,000	October-2021	105% of CDI	104,328	101,761
September-2012		300,000	October-2021	105% of CDI	312,984	305,282
October-2012		85,000	October-2021	105% of CDI	88,679	86,496
February-2013	(ii)	100,000	February-2016	8.00	101,139	101,183
February-2013	(ii)	50,000	February-2016	7.50	50,494	50,505
February-2013	(ii)	100,000	February-2016	8.00	101,010	101,010
February-2013	(ii)	50,000	February-2016	8.00	50,419	50,440
February-2013	(ii)	100,000	February-2016	8.00	100,967	100,923
March-2013	(ii)	50,000	March-2016	8.00	50,257	50,257
March-2013	(ii)	17,500	March-2016	8.00	17,590	17,583
August-2013	(ii)	10,000	August-2016	8.00	10,120	10,129
December-2013	(ii)	150,000	December-2016	8.00	153,176	150,257
March-2014		10,354	June-2014	8.00	10,354
March-2014		55,446	June-2014	8.00	55,446
Total		2,608,300			2,623,356	2,528,077

(i) The Company enters into swap transactions to offset the variation in the Interbank Certificate of Deposit (CDI) rate (Note 14.1.1 (b)).

(ii) The Company enters into swap transactions for these contracts (from 67.47% to 92.70% of CDI) (Note 14.1.1 (a)).

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(e) Payment schedule

The maturity profile of the long-term amounts is as follows:

	Mar/2014	Dec/2013
2015	970,152	1,121,998
2016	2,105,368	1,738,496
2017	995,017	1,576,790
2018	1,392,106	1,881,848
2019	1,523,297	1,479,686
2020	1,901,769	2,366,125
2021	2,464,661	2,561,516
2022	1,191,406	1,248,355
2023	2,513	1,676
2024	1,128,970
2025 and thereafter	3,246,850	3,377,197
Total	16,922,109	17,353,687

(f) Capitalized financial charges

The Company capitalized financial charges in the period ended March 31, 2014 in the amount of R$19,842 (R$23,258 in the period ended March 31, 2013), including monetary variation and part of the exchange variation. The average rate of these charges in the period was 7.41% p.a. (6.98% p.a. in the first quarter of 2013).

(g) Guarantees

Braskem gave collateral for part of its borrowings as follows:

		Total debt	Total
Loans	Maturity	Mar/2014	guaranteed	Guarantees

BNB	March-2023	328,561	328,561	Mortgage of plants, pledge of machinery and equipment
BNDES	January-2021	2,820,085	2,820,085	Mortgage of plants, land and property, pledge of machinery and equipment
FUNDES	June-2020	199,706	199,706	Mortgage of plants, land and property, pledge of machinery and equipment
FINEP	August-2023	116,956	116,956	Bank surety
FINAME	February-2022	3,273	3,273	Pledge of equipment
Total		3,468,581	3,468,581

(h) Financial covenants

The Company has not entered into financing agreements that establish limits for certain indicators related to the capacity to contract debt and pay interest.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

13. Project finance

The information on project finance was presented in the 2013 annual financial statements in Note 20.

Identification	US$ thousands	US$ thousands	Maturity	Charges (% per year)	Mar/2014	Dec/2013
Project finance I	700,000	484,847	February-2027	Us dollar exchange variation + quarterly Libor + 3.25	1,102,285	1,141,515
Project finance II	210,000	51,422	February-2027	Us dollar exchange variation + 6.17	180,209	121,387
Project finance III	600,000	263,264	February-2029	Us dollar exchange variation + 4.33	599,833	621,410
Project finance IV	660,000	551,173	February-2029	Us dollar exchange variation + quarterly Libor + 3.88	1,191,225	1,298,791
Project finance V	400,000	277,055	February-2029	Us dollar exchange variation + quarterly Libor + 4.65	630,702	653,288
Project finance VI	90,000	33,811	February-2029	Us dollar exchange variation + quarterly Libor + 2.73	76,896	79,630
Project finance VII	533,095	369,242	February-2029	Us dollar exchange variation + quarterly Libor + 4.64	849,442	866,581
Transactions costs					(48,756)	(51,196)
Total	3,193,095	2,030,814			4,581,836	4,731,406

Current liabilities					22,676	25,745
Non-current liabilities					4,559,160	4,705,661
Total					4,581,836	4,731,406

Braskem Idesa capitalized the charges incurred on this financing in the period ending March 31, 2014, in the amount of R$72,289 (MXN$ 394,257 thousand) (R$99,009 (MXN$606,676 thousand) in the period ended March 31, 2013, related to contributions by Braskem and the non-controlling shareholder, lent in advance, and reimbursed with the proceeds from the Project Finance. The average interest rate in the period was 5.02% p.a.

The maturity profile of this long-term financing, by year of maturity, is as follows:

	Mar/2014	Dec/2013
2016	85,198	85,068
2017	251,066	254,883
2018	308,654	313,944
2019	321,612	327,391
2020	381,870	389,584
2021	438,173	447,535
2022	368,623	377,156
2023	483,189	493,770
2024	523,178	534,866
2025 and thereafter	1,397,597	1,481,464
Total	4,559,160	4,705,661

In accordance with the Company’s risk management strategy and based on its financial policy, the Management contracted and designated derivative operations under hedge accounting (Note 14.2.1 (c.ii.i)) in order to offset the change in future debt-related financial expenses caused by the fluctuation of the Libor rate.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

14. Financial instruments

The information related to financial instruments was presented in the 2013 financial statements of the Company, in Note 21.

14.1. Non-derivative financial instruments – measured at fair value

			Fair value	Book value		Fair value
	Note	Classification by category	hierarchy	Mar/2014	Dec/2013	Mar/2014	Dec/2013

Cash and cash equivalents	3
Cash and banks		Loans and receivables		240,089	987,824	240,089	987,824
Financial investments in Brazil		Held-for-trading	Level 2	526,937	687,938	526,937	687,938
Financial investments in Brazil		Loans and receivables		1,132,989	1,218,852	1,132,989	1,218,852
Financial investments abroad		Held-for-trading	Level 2	1,314,050	1,441,245	1,314,050	1,441,245
				3,214,065	4,335,859	3,214,065	4,335,859

Financial investments	4
FIM Sol investments		Held-for-trading	Level 2	66,962	61,670	66,962	61,670
Investments in foreign currency		Held-for-trading	Level 2	2,955	3,773	2,955	3,773
Investments in foreign currency		Held-to-maturity		359	189	359	189
Shares		Held-for-trading		1,170	1,170	1,170	1,170
Quotas of receivables investment fund Restricted deposits		Held-to-maturity		42,003	40,696	42,003	40,696
				113,449	107,498	113,449	107,498

Trade accounts receivable	5	Loans and receivables		2,848,750	2,872,395	2,848,750	2,872,395

Related parties credits	7	Loans and receivables		591,047	258,136	591,047	258,136

Trade payables		Other financial liabilities		9,959,674	10,421,687	9,959,674	10,421,687

Borrowings	12
Foreign currency - Bond		Other financial liabilities	Level 1	10,061,916	10,432,526	9,890,817	10,241,359
Foreign currency - other borrowings		Other financial liabilities		2,650,866	2,588,901	2,650,866	2,588,901
Local currency		Other financial liabilities		5,679,415	5,667,529	5,679,415	5,667,529
				18,392,197	18,688,956	18,221,098	18,497,789

Project finance	13	Other financial liabilities		4,630,592	4,782,602	4,630,592	4,782,602

Other payables
Creditors for the acquisitions of shares		Other financial liabilities		280,831	275,743	280,831	275,743
Accounts payable to non-controlling (Braskem Idesa)		Other financial liabilities		478,578	341,993	478,578	341,993
				759,409	617,736	759,409	617,736

(a) Fair value hierarchy

Level 1 – fair value obtained through prices quoted (without adjustments) in active markets for identical assets or liabilities, such as the stock exchange; and

Level 2 – fair value obtained from discounted cash flow models, when the instrument is a forward purchase or sale or a swap contract, or valuation models of option contracts, such as the Black-Scholes model, when the derivative has the characteristics of an option.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

14.1.1 Financial derivatives instruments designated and not designated for hedge accounting

Operation characteristics

Fair value

Principal exposure

Balance at

Change in

Financial

Balance at

Identification

Note

hierarchy

Derivatives

Dec/2013

fair value

settlement

Mar/2014

Non-hedge accounting transactions

Commodity swap - Naphtha

Level 2

Fixed price

Variable price

(470)

112

(290)

Interest rate swaps

14.1.1 (a)

Level 2

Fixed rate

CDI

20,751

4,372

(983)

24,140

Contract for the future purchase

Level 2

Euro

Dollar

(5,022)

618

2,741

(1,663)

15,259

5,058

1,870

22,187

Hedge accounting transactions

Exchange swap

14.1.1 (b)

Level 2

CDI

Dollar

367,559

(17,052)

(6,421)

344,086

Commodity swap - ethylene

Level 2

Variable price

Fixed price

(69)

199

107

237

Commodity swap - PGP

Level 2

Fixed price

Variable price

(59)

(387)

(351)

Interest rate swaps

14.1.1 (d.i)

Level 2

Libor

Dollar

(110,253)

34,121

6,447

(69,685)

Contract for the future purchase - Currency

14.1.1 (d.ii)

Level 2

Peso mexicano

Dollar

47,280

(7,780)

(15,785)

23,715

304,458

9,101

(15,557)

298,002

319,717

320,189

The regular changes in the fair value of derivatives not designated as hedge accounting were recorded as financial income or expenses in the same period in which they occur. In the period ended March 31, 2014, the Company recognized a financial expense of R$16,189 (financial income of R$45,035 in the period ended March 31, 2013).

(a) Interest rate swap linked to NCE

Identification		Interest rate	Maturity		Fair value
Identification	Nominal value	(hedge)	Maturity	Mar/2014	Dec/2013
Swap NCE I	100,000	90.65% CDI	February-2016	4,406	4,086
Swap NCE II	50,000	88.20% CDI	February-2016	2,372	2,243
Swap NCE III	100,000	92.64% CDI	February-2016	4,725	4,435
Swap NCE IV	50,000	92.70% CDI	February-2016	2,423	2,315
Swap NCE V	100,000	91.92% CDI	February-2016	4,638	4,407
Swap NCE VI	50,000	92.25% CDI	March-2016	2,434	2,310
Swap NCE VII	17,500	91.10% CDI	March-2016	808	765
Swap NCE VIII	10,000	77.52% CDI	August-2016	239	190
Swap NCE IX	50,000	68.15% CDI	December - 2016	821
Swap NCE X	50,000	67.15% CDI	December - 2016	647
Swap NCE XI	50,000	67.10% CDI	December - 2016	627
Total	627,500			24,139	20,751

Current liabilities (derivatives operations)				24,140	20,751
Total				24,140	20,751

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(b) Swaps related to export credit notes (NCE)

Identification		US$ thousands	Interest rate	Maturity	Fair value
Identification	Nominal value	(hedge)	(hedge)	Maturity	Mar/2014	Dec/2013
Swap NCE I	200,000	122,100	5.44%	August 2019	96,583	101,904
Swap NCE II	100,000	60,187	5.40%	August 2019	45,813	48,414
Swap NCE III	100,000	59,588	5.37%	August 2019	44,083	46,642
Swap NCE IV	100,000	56,205	5.50%	April 2019	36,048	39,005
Swap NCE V	100,000	56,180	5.50%	April 2019	35,983	38,939
Swap NCE VI	150,000	82,372	5.43%	April 2019	37,116	52,745
Swap NCE VII	100,000	58,089	4.93%	April 2019	48,460	39,910
Total	850,000	494,721			344,086	367,559

Current assets (other receivables)					(36,516)	(28,481)
Non Current liabilities (derivatives operations)					380,602	396,040
Total					344,086	367,559

(c) Non-derivative liabilities designated for export hedge accounting

On May 1, 2013, Braskem S.A. designated non-derivative financial instrument liabilities, denominated in U.S. dollars, as hedge for the flow of its highly probable future exports. On March 31, 2014, the following non-derivative liabilities were designated as hedge for the flow of its highly probable future exports:

			Nominal value
Identification	Maturity	Hedge	US$ thousands	Mar/2014	Dec/2013
Operations designated for hedge accounting
Trade payables	2016	Dollar	839,447	1,899,668	1,966,488
Trade payables	2017	Dollar	749,685	1,696,537	1,756,212
Export prepayments - related parties	2017	Dollar	80,000	181,040	187,408
Trade payables	2018	Dollar	787,894	1,783,003	1,744,207
Export prepayments - related parties	2018	Dollar			101,513
Bond	2019	Dollar	65,143	147,419	152,604
Trade payables	2019	Dollar	50,000	113,150	117,130
Export prepayments	2019	Dollar	618,836	1,400,428	1,449,688
Accounts payable	2020	Dollar	288,000	651,744	674,669
Trade payables	2020	Dollar	56,000	126,728	131,186
Export prepayments	2020	Dollar	380,000	859,940	890,188
Accounts payable	2021	Dollar	332,000	751,316	777,743
Trade payables	2021	Dollar	10,000	22,630	23,426
Export prepayments	2021	Dollar	374,000	846,362	876,132
Accounts payable	2022	Dollar	216,000	488,808	506,002
Export credit note	2022	Dollar	353,000	798,839	826,938
Export prepayments	2022	Dollar	150,000	339,450	351,388
Accounts payable	2023	Dollar	653,972	1,479,938	1,531,994
Export prepayments	2023	Dollar	64,400	145,737	150,863
Accounts payable	2024	Dollar	113,854	257,652	266,715
Export prepayments	2024	Dollar	575,000	1,301,225	1,346,995
			6,757,231	15,291,614	15,829,489

(d) Hedge operations by Braskem Idesa related to project finance

The hedge operations of Braskem Idesa follow the same mode as project finance, whereby the project loan must be paid exclusively with the cash generated by the project itself and shareholders provide limited guarantees (limited recourse project finance) (Note 13).

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

The periodic changes in the fair value of derivatives not designated as hedge accounting were recorded as financial income or expense in the same period in which they occur. In the period ended March 31, 2014, the Company recognized a financial expense of R$18,036.

(d.i) Interest rate swap linked to Libor

Identification	Nominal value	Interest rate	Maturity		Fair value
Identification	US$ thousands	(hedge)	Maturity	Mar/2014	Dec/2013
Swap Libor I	299,996	1.9825%	May-2025	(15,879)	(25,124)
Swap Libor II	299,996	1.9825%	May-2025	(15,980)	(25,213)
Swap Libor III	299,996	1.9825%	May-2025	(15,879)	(25,213)
Swap Libor IV	129,976	1.9825%	May-2025	(6,924)	(10,924)
Swap Libor V	132,996	1.9825%	May-2025	(7,040)	(11,178)
Swap Libor VI	149,932	1.9825%	May-2025	(7,983)	(12,601)
Total	1,312,892			(69,685)	(110,253)

Current Assets (other receivables)				(1,409)
Non-Current assets (other receivables)				(100,995)	(137,345)
Current liabilities (derivatives operations)				32,719	27,092
Total				(69,685)	(110,253)

(d.ii) Currency futures contract– Mexican Peso

Identification	Nominal value	Foreign exchange	Maturity		Fair value
Identification	US$ thousands	(hedge)	Maturity	Mar/2014	Dec/2013
Deliverable Forward	41,020	12.6185	January-2014		3,620
Deliverable Forward	35,453	12.5394	February-2014		3,815
Deliverable Forward	39,206	12.5926	March-2014		4,065
Deliverable Forward	54,084	12.8643	April-2014	2,127	3,468
Deliverable Forward	52,182	12.9268	June-2014	1,755	3,164
Deliverable Forward	51,191	12.8909	June-2014	2,307	3,624
Deliverable Forward	46,889	12.8789	July-2014	2,457	3,612
Deliverable Forward	45,959	12.9465	September-2014	2,130	3,281
Deliverable Forward	36,561	12.9044	September-2014	2,113	2,988
Deliverable Forward	37,215	12.9570	Octuber-2014	2,008	2,923
Deliverable Forward	31,908	12.9465	December-2014	1,930	2,707
Deliverable Forward	28,169	12.9881	December-2014	1,650	2,344
Deliverable Forward	23,381	12.9518	February-2015	1,651	2,202
Deliverable Forward	29,047	13.1969	March-2015	1,029	1,788
Deliverable Forward	18,625	13.0980	March-2015	1,066	1,519
Deliverable Forward	10,230	13.0490	April-2015	722	961
Deliverable Forward	5,897	13.1167	June-2015	384	525
Deliverable Forward	7,014	13.4329	June-2015	128	317
Deliverable Forward	2,245	13.2538	July-2015	120	176
Deliverable Forward	1,840	13.1486	August-2015	138	181
Total	598,123			23,715	47,280

Current liabilities (derivatives operations)				22,311	47,280
Non-Current liabilities (derivatives operations)				1,404
Total				23,715	47,280

Before designating these swap operations as hedge accounting, on March 1, 2014, the Company recognized financial income of R$112 as profit in the period. After recognizing such designation, in shareholders’ equity, the Company recognized financial expense of R$7,768 relating to changes in the fair value of these swaps since the designation through March 31, 2014.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(e) Estimated maximum loss

The amount at risk of the derivatives held by Braskem on March 31, 2014, which is defined as the highest loss that could result in one month and in 95% of the cases under normal market conditions, was estimated by the Company at R$27,548 (US$12,173 thousand) for the NCE swap designated for hedge accounting and R$1,888 for the NCE swap that is not designated for hedge accounting.

The value at risk of derivatives related to the Ethylene XXI Project in Mexico in 95% of the cases, under normal market conditions, was estimated at R$21,123 (US$9,334 thousand) for the Libor derivative and R$1,577 (US$697 thousand) for the derivative of Mexican pesos.

14.2. Credit quality of financial assets

(a) Trade accounts receivable

On March 31, 2014, the credit ratings for the domestic market were as follows:

				(%)
			Mar/2014	Dec/2013
1	Minimum risk		7.28	16.56
2	Low risk		36.01	32.61
3	Moderate risk		32.02	23.54
4	High risk		23.79	26.26
5	Very high risk	(i)	0.90	1.03

(i) Most clients in this group are inactive and the respective accounts are in the process of collection actions in the courts. Clients in this group that are still active buy from Braskem and pay in advance.

Default indicators for the periods ended:

	Last 12 months
	Domestic	Export
	Market	Market
March 31, 2014	0.31%	0.60%
March 31, 2013	0.79%	0.27%
December 31, 2013	0.14%	0.13%
December 31, 2012	0.28%	0.37%

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(b) Other financial assets

In order to determine the credit ratings of counterparties in financial assets classified as cash and cash equivalents, held-for-trading, held-to-maturity and loans and receivables, Braskem uses the following credit rating agencies: Standard & Poor’s, Moody’s and Fitch Ratings.

	Mar/2014	Dec/2013
Financial assets with risk assessment
AAA	2,918,328	3,436,378
AA	56,489	93,955
A	305,006	865,105
A-		1,485
	3,279,823	4,396,923
Financial assets without risk assessment
Quotas of investment funds in credit rights (i)	42,003	40,696
Sundry funds (ii)	2,955	3,773
Other financial assets with no risk assessment	2,733	1,965
	47,691	46,434

Total	3,327,514	4,443,357

(i) Financial assets with no internal or external ratings and approved by the Management of the Company.

(ii) Investment funds with no internal and external risk assessment whose portfolio is composed of assets from major financial institutions and that comply with Braskem’s financial policy.

Braskem’s financial policy determines “A-” as the minimum rating for financial investments.

14.3. Sensitivity analysis

Financial instruments, including derivatives, may be subject to changes in their fair value as a result of the variation in commodity prices, foreign exchange rates, interest rates, shares and share indexes, price indexes and other variables. The sensitivity of the derivative and non-derivative financial instruments to these variables are presented below:

(a) Selection of risks

On March 31, 2014, the main risks that can affect the value of Braskem’s financial instruments are:

· Brazilian real/U.S. dollar exchange rate;

· U.S. dollar/Mexican peso exchange rate;

· U.S. dollar/Euro exchange rate;

· Libor floating interest rate;

· CDI interest rate; and

· TJLP interest rate.

For the purposes of the risk sensitivity analysis, Braskem presents the exposures to currencies as if they were independent, that is, without reflecting in the exposure to a foreign exchange rate the risks of the variation in other foreign exchange rates that could be directly influenced by it.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(b) Selection of scenarios

(b.1) Probable scenario

The Market Readout published by the Central Bank of Brazil on March 28, 2014 was used to create the probable scenario for the U.S. dollar/Brazilian real exchange rate and the CDI interest rate, using the reference date of March 31, 2014. The Market Readout presents a consensus of market expectations based on a survey of the forecasts made by various financial and non-financial institutions.

The Market Readout does not publish forecasts for the interest rates Libor and TJLP. Therefore, Braskem considered the expectations for the CDI interest rate for determining the probable scenario for those rates, given their correspondence. The probable scenario for the TJLP is an increase of 0.5% from the current rate of 5%, in line with the size of the government’s most recent decisions to increase or decrease the rate, and accompanying the forecast for the cumulative increase in the CDI rate by end-2014 of 0.50%.

(b.2) Possible and extreme adverse scenarios

The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario and show the changes in future cash flows:

			Possible adverse	Extreme adverse
Instrument	Sensibility	Probable	(25%)	(50%)
Bonds and MTN	Brazilian real/U.S. dollar exchange rate	(813,968)	(2,462,579)	(4,925,159)
Advance on exchange contracts	Brazilian real/U.S. dollar exchange rate	(9,369)	(28,346)	(56,693)
BNDES	Brazilian real/U.S. dollar exchange rate	(34,088)	(103,131)	(206,261)
Working capital / structured operations	Brazilian real/U.S. dollar exchange rate	(132,108)	(399,681)	(799,361)
Raw material financing	Brazilian real/U.S. dollar exchange rate	(103)	(310)	(621)
Export prepayments	Brazilian real/U.S. dollar exchange rate	(43,382)	(131,249)	(262,497)
Financial investments abroad	Brazilian real/U.S. dollar exchange rate	140,176	424,088	848,177
Swaps	Brazilian real/U.S. dollar exchange rate	104,083	314,919	629,783
Project finance	U.S. dollar/Mexican peso exchange rate	(73,375)	(506,168)	(1,012,337)
Deliverable Forward	U.S. dollar/Mexican peso exchange rate	(36,429)	(211,009)	(352,413)
Deliverable Forward	U.S. dollar/Euro exchange rate	(239)	(37,267)	(74,536)
Borrowings	Libor floating interest rate	(1,322)	(6,612)	(13,223)
Export prepayments	Libor floating interest rate	(2,039)	(10,193)	(20,387)
Swaps	Libor floating interest rate	1,568	(7,840)	(15,680)
Export credit notes	CDI interest rate	(7,865)	(21,159)	(40,916)
Agricultural credit note	CDI interest rate	(81,284)	(208,189)	(374,179)
Financial investments in local currency	CDI interest rate	(16,726)	(45,985)	(91,937)


		Probable	Possible adverse	Extreme adverse
Instrument	Sensibility	5.50%	6.00%	6.50%
BNDES	TJLP interest rate	(42,537)	(83,993)	(124,400)
FINEP	TJLP interest rate	(98)	(194)	(289)
Other governmental agents	TJLP interest rate	(38)	(76)	(114)

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

15. Taxes payable

The information related to taxes payable was presented in the Company’s 2013 annual financial statements, in Note 22.

		Mar/2014	Dec/2013

Brazil
	IPI	92,204	81,282
	PIS and COFINS	667	615
	Income tax and social contribution	90,793	52,226
	ICMS	105,905	120,941
	Federal tax payment program - Law 11,941/09	1,011,935	1,024,127
	Other	56,698	67,680

Other countries
	Other	2,866	1,428
Total		1,361,068	1,348,299

Current liabilities		473,325	445,424
Non-current liabilities		887,743	902,875
Total		1,361,068	1,348,299

16. IR and CSL

The information related to income tax and social contribution was presented in the Company’s 2013 annual financial statements, in Note 23.

(a) Reconciliation of the effects of IR and CSL

	Note	Mar/2014	Mar/2013
	2.1.1(b)		Revised
Income before IR and CSL		569,133	339,764

IR and CSL at the rate of 34%		(193,505)	(115,520)

Permanent adjustments to the IR and CSL calculation basis
IR and CSL on equity in results of investees		(8,057)	(1,605)
Other permanent adjustments		28,772	10,259

Effect of IR and CSL on results of operations		(172,790)	(106,866)

Breakdown of IR and CSL:

Current IR and CSL		(53,456)	(43,883)
Deferred IR and CSL		(119,334)	(62,983)
Total IR and CSL on income statement		(172,790)	(106,866)

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

Braskem has subsidiaries abroad, whose nominal IR rate differs from those in Brazil, of 34% (IR – 25% and CSL – 9%), as shown below:

	Official rate - %
	Headquarters
	(Country)	Mar/2014

Direct and Indirect subsidiaries
Braskem Alemanha	Germany	31.90
Braskem America e Braskem America Finance	USA	35.00
Braskem Argentina	Argentina	35.00
Braskem Austria e Braskem Austria Finance	Austria	25.00
Braskem Chile e Petroquímica Chile	Chile	20.00
Braskem Espanha	Spain	30.00
Braskem Finance e Braskem Inc	Cayman Islands (*)
Braskem Holanda	Netherland	25.00
Braskem Idesa, Braskem Idesa Serviços, Braskem México and Braskem México Serviços	Mexico	30.00
Common	British Virgin Islands (*)
Lantana	Bahamas (*)
Norfolk	Uruguay	25.00

(*) Country with favored taxation – rate of 0%.

(b) Breakdown of deferred income tax and social contribution

Deferred tax - assets
	Mar/2014	Dec/2013
Tax losses (IR) and negative base (CSL)	1,000,037	1,015,587
Goodwill amortized	11,320	12,065
Exchange variations	586,068	791,508
Temporary adjustments	370,234	408,233
Business combination	233,393	232,039
Pension plan	78,586	61,927
Deferred charges - write-off	57,110	37,971
Investiments in subsidiaries		94,276
	2,336,748	2,653,606

Deferred tax - liabilities

Amortization of goodwill based on future profitability	661,842	643,050
Tax depreciation	584,197	541,325
Temporary differences	362,609	426,186
Business combination	575,394	585,250
Write-off negative goodwill of incorporated subsidiaries	1,039	1,187
Additional indexation PP&E	136,649	140,157
Other	55,890	56,543
	2,377,620	2,393,698

Deffered tax net	(40,872)	259,908

Asset in Balance Sheet	806,852	1,123,313
(-) Liability in Balance Sheet	847,724	863,405

Deffered tax net	(40,872)	259,908

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(c) Net balance of deferred IR and CSL assets and liabilities

		Mar/2014
	Headquarters (Country)	IR-CSL Asset	IR-CSL Liability	Net

Assets
Braskem S.A.	Brazil	1,507,558	(1,122,113)	385,445
Braskem Argentina	Argentina	6,467		6,467
Braskem Alemanha	Germany	70,524		70,524
Braskem Idesa	Mexico	9,663		9,663
Braskem Petroquímica	Brazil	209,176	(135,790)	73,386
Braskem Qpar	Brazil	383,975	(271,913)	112,062
Petroquímica Chile	Chile	113	(80)	33
IQAG	Brazil	22		22
Quantiq	Brazil	5,626		5,626
Braskem Qpar - business combination effect	Brazil	143,624		143,624
		2,336,748	(1,529,896)	806,852
Liabilities
Braskem Qpar - business combination effect	Brazil		(492,387)	(492,387)
Braskem America	USA		(355,337)	(355,337)
			(847,724)	(847,724)

		Dec/2013
	Headquarters (Country)	IR-CSL Asset	IR-CSL Liability	Net
Assets
Braskem S.A.	Brazil	1,769,683	(1,095,410)	674,273
Braskem Argentina	Argentina	5,552		5,552
Braskem Alemanha	Germany	67,910		67,910
Braskem Idesa	Mexico	57,613	(52,554)	5,059
Braskem Petroquímica	Brazil	215,348	(129,022)	86,326
Braskem Qpar	Brazil	390,017	(253,307)	136,710
Petroquímica Chile	Chile	123		123
IQAG	Brazil	23		23
Quantiq	Brazil	5,069		5,069
Braskem Qpar - business combination effect	Brazil	142,268		142,268
		2,653,606	(1,530,293)	1,123,313

Liabilities
Braskem Qpar - business combination effect	Brazil		(501,699)	(501,699)
Braskem America	USA		(361,706)	(361,706)
			(863,405)	(863,405)

(d) Realization of deferred IR and CSL

In the period ended March 31, 2014, there were no material events or circumstances that indicate any compromise of the realization of these deferred taxes.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

17. Sundry provisions

The information on sundry provisions was presented in the 2013 annual financial statements of the Company, in Note 24.


	Mar/2014	Dec/2013
Measures to
Provision for customers bonus	34,209	45,060
Provision for recovery of environmental damages	119,297	132,762
Judicial and administrative provisions	376,074	362,896
Other	11,419	14,832
Total	540,999	555,550

Current liabilities	88,019	105,856
Non-current liabilities	452,980	449,694
Total	540,999	555,550

The composition of provisions for judicial and administrative suits is as follows:

	Mar/2014	Dec/2013

Labor claims	124,878	125,887

Tax claims
Income tax and social contribution	33,068	32,319
PIS and COFINS	36,499	35,634
ICMS - interstate purchases	88,327	86,233
ICMS - other	11,710	11,432
Other	71,573	61,372

Societary claims and other	10,019	10,019
	376,074	362,896

18. Post-employment (defined-benefit plans)

The information on post-employment (defined-benefit plans) was presented in the 2013 annual financial statements of the Company, in Note 26.

The amounts recognized are as follows:

		Mar/2014	Dec/2013

Petros Plans	(a)	235,134	158,122
Novamont Braskem America		7,509	9,554
Braskem Alemanha		34,386	34,515
		277,029	202,191

Current liabilities			158,137
Non-current liabilities		277,029	44,054
Total		277,029	202,191

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(a) Petros Plans

In August and October 2012, the Brazilian Private Pension Plan Superintendence (PREVIC - Superintendência Nacional de Previdência Complementar) approved the withdrawal of the sponsorship by Braskem of these plans, which required the payment of the mathematical reserves of the respective beneficiaries and in turn the monetization of the assets of the plans managed by Petros. In view of the unlikelihood of said monetization after almost two years since the approval by PREVIC, Management of the Company had no other option but to start all necessary procedures to resume the sponsorship of the plans. This decision was formalized through a legal injuction dated April 3 2014 that had the main goal of safeguarding Braskem’s rights. Management expects that during the next months, the conditions for the resumption of sponsorship of the plan, including the preparation of the actuarial reports, would be established as a result of the discussions that will necessarily be conducted with PREVIC and Petros. The provision booked by the Company, measured based on the criteria that has been adopted since the decision to withdraw sponsorship, was increased by the estimate of the past service cost (Note 23) and was reclassified to non-current liabilities.

19. Contingencies

Braskem has contingent liabilities related to lawsuits and administrative proceedings arising from the normal course of its business, of a labor and social security, tax, civil and corporate nature, which involve risks of losses that are classified by the Company’s management as possible.

In the quarter ended March 31, 2014, there were no material events or changes in the previsions reported on December 31, 2013.

A detailed presentation of the Company’s contingent liabilities was presented in the 2013 financial statements, in Note 29.

20. Equity

The information related to the Company’s shareholders’ equity was presented in its 2013 annual financial statements, in Note 30.

(a) Capital

		Shares unit
				Preferred		Preferred
		Common		shares		shares
		shares	%	class A	%	class B	%	Total	%

OSP e Odebrecht		226,334,623	50.11%	79,182,498	22.96%			305,517,121	38.32%
Petrobras		212,426,951	47.03%	75,479,347	21.88%			287,906,298	36.11%
BNDESPAR			0.00%	40,102,837	11.62%			40,102,837	5.03%
ADR	(i)		0.00%	34,191,744	9.91%			34,191,744	4.29%
Other		12,907,078	2.86%	114,891,694	33.30%	593,818	100.00%	128,392,590	16.10%
Total		451,668,652	100.00%	343,848,120	99.67%	593,818	100.00%	796,110,590	99.86%
Braskem shares owned by Braskem Petroquímica	(ii)			1,154,758	0.33%			1,154,758	0.14%
Total		451,668,652	100.00%	345,002,878	100.00%	593,818	100.00%	797,265,348	100.00%

(i) American Depositary Receipts traded on the New York Stock Exchange (USA);

(ii) These share are considered “treasury shares” in the consolidated shareholders’ equity, amounting to R$48,892.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

(b) Other comprehensive income - shareholders' equity

Defined

Foreign

Additional

Deemed

benefit

currency

Loss

indexation of

cost of

plan actuarial

Fair value

translation

on interest

PP&E

Gain (loss)

of hedge

adjustment

in subsidiary

(i)

(ii)

(iii)

(iv)

(v)

Total

At December 31, 2012

299,305

20,207

(11,816)

37,158

(7,443)

337,411

Additional indexation

Realization by depreciation or write-off assets

(10,317)

IR and CSL

3,508

Deemed cost of jointly-controlled investment

Realization by depreciation or write-off assets

(367)

IR and CSL

125

Loss on interest in subsidiary

(1,980)

Foreign currency translation adjustment

(6,821)

At March 31, 2013

292,496

19,965

(11,816)

30,337

(9,423)

321,559

At December 31, 2013

272,069

19,240

(11,647)

(1,605,356)

242,407

(9,404)

(1,092,691)

Additional indexation

Realization by depreciation or write-off assets

(10,317)

IR and CSL

3,507

Deemed cost of jointly-controlled investment

Realization by depreciation or write-off assets

(366)

IR and CSL

125

Foreign sales hedge

Exchange rate

537,876

IR and CSL

(182,878)

Fair value of Cash flow hedge

Change in fair value

8,431

Transfer to result

1,217

IR and CSL

(8,395)

Foreign currency translation adjustment

(46,134)

At March 31, 2014

265,259

18,999

(11,647)

(1,249,105)

196,273

(9,404)

(789,625)

(i)

Realization as the asset is depreciated or written-off.

(ii)

Realization upon extinction of the plan.

(iii)

Realization upon maturity, prepayment or loss of efficacy for hedge accounting.

(iv)

Realization upon write-off of subsidiary abroad.

(v)

Realization upon divestment or transfer of control of subsidiary.

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

21. Earnings per share

The information related to the earnings per share of the Company was presented in its 2013 annual financial statements, in Note 31.

The table below shows the reconciliation of profit or loss for the period adjusted for the amounts used to calculate basic and diluted earnings per share.


		Basic and diluted

	Note	Mar/2014	Mar/2013
	2.1.1(b)		Revised

Profit for the period attributed to Company's shareholders		405,306	216,007

Distribution of dividends attributable to priority:
Preferred shares class "A"		208,437	208,437
Preferred shares class "B"		360	360
		208,797	208,797

Distribution of the remaining results to common shares		196,509	7,210

Reconciliation of income available for distribution, by class (numerator):
Common shares		196,509	7,210
Preferred shares class "A"		208,437	208,437
Preferred shares class "B"		360	360
		405,306	216,007

Weighted average number of shares, by class (denominator):
Common shares		451,668,652	451,668,652
Preferred shares class "A"		343,848,120	343,848,120
Preferred shares class "B"		593,818	593,818
		796,110,590	796,110,590

Profit (loss) per share (in R$)
Common shares		0.4351	0.0160
Preferred shares class "A"		0.6062	0.6062
Preferred shares class "B"		0.6062	0.6062

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

22. Net sales revenues

The information on net sales revenue was presented in the 2013 annual financial statements of the Company, in Note 32.

		Note	Mar/2014	Mar/2013
		2.1.1(b)		Revised
Sales revenue
	Domestic market		8,505,375	7,478,061
	Foreign market		5,125,059	3,836,079
			13,630,434	11,314,140
Sales deductions
	Taxes		(1,688,017)	(1,697,059)
	Sales returns and other		(99,791)	(115,911)
			(1,787,808)	(1,812,970)

Net sales revenue			11,842,626	9,501,170

23. Other operating income (expenses)

In the period ended March 31, 2014, the main effects on this item were as follows:

· Gain on sale of DAT (Note 1(a.ix)):

			DAT
			Amount
Sale amount			315,000
Cost amount of the investment sold in the divestment date			(37,662)
Gain on sale			277,338

· Expense with additional provision accrued for the Petros Plans in the amount of R$65,000 (Note 18(a)).

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

24. Financial results

The information on financial results was presented in the 2013 annual financial statements of the Company, in Note 35.

		Note	Mar/2014	Mar/2013
		2.1.1(b)		Revised
Financial income
	Interest income		52,124	34,582
	Monetary variations		16,719	2,527
	Exchange rate variations		(60,899)	42,497
	Other		8,939	43,506
			16,883	123,112

Financial expenses
	Interest expenses		(306,859)	(237,231)
	Monetary variations		(85,866)	(73,160)
	Exchange rate variations		53,865	284,996
	Inflation adjustments on fiscal debts		(30,425)	(24,992)
	Tax expenses on financial operations		(2,760)	(2,944)
	Discounts granted		(31,293)	(14,541)
	Loans transaction costs - amortization		(6,777)	(2,113)
	Adjustment to present value - appropriation		(141,992)	(137,162)
	Other		(24,921)	(23,766)
			(577,028)	(230,913)

			(560,145)	(107,801)

	Note	Mar/2014	Mar/2013
	2.1.1(b)		Revised
Interest income - Origens by application type
Held for sale		373	1,098
Loans and receivables		32,759	22,453
Held-to-maturity		8,558	2,918
		41,690	26,469
Other assets not classifiable		10,434	8,113
Total		52,124	34,582

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

25. Expenses by nature

The information on expenses by nature was presented in the 2013 annual financial statements of the Company, in Note 36.

		Note	Mar/2014	Mar/2013
		2.1.1(b)		Revised
Classification by nature:
	Raw materials other inputs		(8,939,861)	(7,210,508)
	Personnel expenses		(530,148)	(450,448)
	Outsourced services		(418,358)	(378,765)
	Tax expenses		(3,257)	(1,856)
	Depreciation, amortization and depletion		(501,105)	(480,924)
	Freights		(386,191)	(367,442)
	Other expenses		65,578	(158,940)
	Total		(10,713,342)	(9,048,883)

Classification by function:
	Cost of products sold		(10,324,626)	(8,490,154)
	Selling and distribution		(269,509)	(252,039)
	General and administrative		(275,014)	(253,362)
	Research and development		(34,142)	(24,564)
	Other operating income (expenses), net		189,949	(28,764)
	Total		(10,713,342)	(9,048,883)

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

26. Segment information

The information related to the presentation of information by segment was presented in the 2013 annual financial statements, in Note 37.

		Mar/2014
		Reporting segments					Total			Braskem
		Basic			USA and	Chemical	reportable	Other	Corporate	consolidated		Braskem
	Note	petrochemicals	Polyolefins	Vinyls	Europe	distribution	segments	segments	unit	before eliminations	Eliminations	consolidated

Net sales revenue		6,638,139	4,529,089	699,563	2,042,039	231,348	14,140,178	56,599		14,196,777	(2,354,151)	11,842,626
Cost of products sold		(5,993,749)	(3,807,709)	(645,765)	(1,914,377)	(193,567)	(12,555,167)	(56,912)		(12,612,079)	2,287,453	(10,324,626)
Gross profit		644,390	721,380	53,798	127,662	37,781	1,585,011	(313)		1,584,698	(66,698)	1,518,000

Operating expenses
Selling, general and distribution expenses		(151,098)	(233,081)	(43,075)	(78,459)	(24,159)	(529,872)	(15,423)	(33,370)	(578,665)		(578,665)
Results from equity investments									(6)	(6)		(6)
Other operating income (expenses), net		217,528	(7,609)	1,746	2,795	(3,070)	211,390	784	(22,225)	189,949		189,949
		66,430	(240,690)	(41,329)	(75,664)	(27,229)	(318,482)	(14,639)	(55,601)	(388,722)		(388,722)

Operating profit (loss)		710,820	480,690	12,469	51,998	10,552	1,266,529	(14,952)	(55,601)	1,195,976	(66,698)	1,129,278


		Mar/2013
	2.1.1(b)											Revised
		Reporting segments					Total			Braskem
		Basic			USA and	Chemical	reportable	Other	Corporate	consolidated		Braskem
		petrochemicals	Polyolefins	Vinyls	Europe	distribution	segments	segments	unit	before eliminations	Eliminations	consolidated

Net sales revenue		5,983,719	3,858,051	644,473	1,606,045	207,444	12,299,732	22,026		12,321,758	(2,820,588)	9,501,170
Cost of products sold		(5,555,933)	(3,409,385)	(593,508)	(1,511,245)	(176,504)	(11,246,575)	(24,661)		(11,271,236)	2,781,082	(8,490,154)
Gross profit		427,786	448,666	50,965	94,800	30,940	1,053,157	(2,635)		1,050,522	(39,506)	1,011,016

Operating expenses
Selling, general and distribution expenses		(122,134)	(204,950)	(40,418)	(61,740)	(22,023)	(451,265)	(11,423)	(67,277)	(529,965)		(529,965)
Results from equity investments									(4,722)	(4,722)		(4,722)
Other operating income (expenses), net		(21,446)	(423)	6,664	1,054	291	(13,860)	(2,432)	(12,472)	(28,764)		(28,764)
		(143,580)	(205,373)	(33,754)	(60,686)	(21,732)	(465,125)	(13,855)	(84,471)	(563,451)		(563,451)

Operating profit (loss)		284,206	243,293	17,211	34,114	9,208	588,032	(16,490)	(84,471)	487,071	(39,506)	447,565

Braskem S.A.

Notes to the financial statements

at March 31, 2014

All amounts in thousands of reais, except where stated otherwise

27. Subsequent events

(a) On April 8, 2014, Braskem Idesa received the third tranche of the Project Finance in the amount of R$1,021,760 (US$ 464,986 thousand).

(b) On April 9, 2014, the Annual Shareholders’ Meeting approved the payment of dividends for the fiscal year ended December 31, 2013, in the amount of R$482,593, which will be paid starting April 22, 2014.

(c) On April 16, 2014, Braskem issued $ 250 million in Bonds through the reopening of his Bond with maturing for February 2024 and interest rate of 6.45% per year. The issue was priced at 103% of face, which represents a yield of 6.04% per year. In May 2014, Braskem used the proceeds raised to swap part of the bonds maturing in 2017, 2018 and 2020.

28. Information related to guaranteed securities issued by subsidiaries

Braskem S.A. has fully and unconditionally guaranteed the debt securities issued by Braskem Finance, a 100-percent-owned finance subsidiary of Braskem. There are no significant restrictions on the ability of Braskem to obtain funds from Braskem Finance.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 8, 2014

BRASKEM S.A.


By:	/s/ Mário Augusto da Silva

	Name:	Mário Augusto da Silva
	Title:	Chief Financial Officer

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates offuture economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.